Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/40047

TitleThe choroid plexus transcriptome reveals changes in type I and II interferon responses in a mouse model of Alzheimer's disease
Author(s)Mesquita, Sandro Gabriel Ferreira Dá
Ferreira, Ana C.
Gao, Fuying
Coppola, Giovanni
Geschwind, Daniel H.
Sousa, João Carlos
Neves, Margarida Correia
Sousa, Nuno
Palha, Joana Almeida
Marques, Fernanda
KeywordsAlzheimer’s disease
Aging
Memory
Choroid plexus
Transcriptome
Neuroinflammation
Interferons
Cerebrospinal fluid
Hippocampus
Glial cells
Issue date2015
PublisherElsevier
JournalBrain, Behavior, and Immunity
CitationMesquita, S. D., Ferreira, A. C., Gao, F., Coppola, G., Geschwind, D. H., Sousa, J. C., . . . Marques, F. (2015). The choroid plexus transcriptome reveals changes in type I and II interferon responses in a mouse model of Alzheimer's disease. Brain, Behavior, and Immunity, 49, 280-292. doi: 10.1016/j.bbi.2015.06.008
Abstract(s)Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a marked decline in cognition and memory function. Increasing evidence highlights the essential role of neuroinflammatory and immune-related molecules, including those produced at the brain barriers, on brain immune surveillance, cellular dysfunction and amyloid beta (Aß) pathology in AD. Therefore, understanding the response at the brain barriers may unravel novel pathways of relevance for the pathophysiology of AD. Herein, we focused on the study of the choroid plexus (CP), which constitutes the blood-cerebrospinal fluid barrier, in aging and in AD. Specifically, we used the PDGFB-APPSwInd (J20) transgenic mouse model of AD, which presents early memory decline and progressive Aß accumulation, and littermate age-matched wild-type (WT) mice, to characterize the CP transcriptome at 3, 5-6 and 11-12months of age. The most striking observation was that the CP of J20 mice displayed an overall overexpression of type I interferon (IFN) response genes at all ages. Moreover, J20 mice presented a high expression of type II IFN genes in the CP at 3months, which became lower than WT at 5-6 and 11-12months. Importantly, along with a marked memory impairment and increased glial activation, J20 mice also presented a similar overexpression of type I IFN genes in the dorsal hippocampus at 3months. Altogether, these findings provide new insights on a possible interplay between type I and II IFN responses in AD and point to IFNs as targets for modulation in cognitive decline.
Typearticle
URIhttp://hdl.handle.net/1822/40047
DOI10.1016/j.bbi.2015.06.008
ISSN0889-1591
Publisher versionhttp://www.journals.elsevier.com/brain-behavior-and-immunity/
Peer-Reviewedyes
AccessopenAccess
Appears in Collections:ICVS - Artigos em Revistas Internacionais com Referee

Files in This Item:
File Description SizeFormat 
mesquita sd_final.pdf4,27 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu Currículo DeGóis